The aim of the study is to provide insight into cancer costs and drivers which affect the costs in the Nordic countries and combine them with currently available outcome measures (NORDCAN). To do so clearly defined harmonized cost indicators across the Nordic countries are needed. As a secondary objective of the project, uniform and comparable data specifications developed between the countries, will enable easier updating of the comparisons in the future. The study will also map the Nordic situation on patient-relevant outcome measures (PROM) in each country and relate these to both health economy and outcomes of cancer care. The study will identify key development issues in the data which is collected and the contents of national registries, especially regarding outcome measures.
Contact Sakari Karjalainen, secretary general, Cancer Society of Finland email@example.com